A randomized, double-blind, placebo-controlled, parallel group trial assessing the proportion of patients experiencing anexacerbation and proportion of patients hospitalized for an exacerbation over 6 months during treatment with tiotropium 18 mcg capsule once daily in patients with COPD [chronic obstructive pulmonary disease] in a veter
Phase of Trial: Phase III
Latest Information Update: 27 Mar 2007
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 27 Mar 2007 New trial record.